N-3,4-二甲基异恶唑-5-基-N-磺酰基乙酰胺

N-3,4-二甲基异恶唑-5-基-N-磺酰基乙酰胺（CAS 80-74-0）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的理化数值

在册的记载用途

Readily absorbed from the gastrointestinal tract. In a pharmacokinetic study, the adjustments for variable renal clearances between oral and intravenous administration and using the unbound plasma concentrations, the bioavailability for an oral dose of sulfisoxazole was found to be 0.95 +/- 0.04.The mean urinary excretion recovery following oral administration of sulfisoxazole is 97% within 48 hours, of which 52% is the parent drug, and the remaining as the N4-acetylated metabolite. It is excreted in human milk. Sulfisoxazole and its acetylated metabolites are excreted primarily by the kidneys through glomerular filtration.

同义词与商品名

Sulfisoxazole acetyl; 80-74-0; ACETYL SULFISOXAZOLE; Lipo Gantrisin; acetylsulfafurazole; Acetylsulfisoxazole; GANTRISIN PEDIATRIC; Acetyl sulfafurazole; Sulfafurazole acetyl; Sulfisoxizole acetyl; WBT5QH3KED; NSC-759138; Sulfisoxazole acetyl (USP); Sulfisoxazole acetyl [USP]; N-3,4-Dimethylisoxazol-5-yl-N-sulphanilylacetamide; Acetamide, N-((4-aminophenyl)sulfonyl)-N-(3,4-dimethyl-5-isoxazolyl)-

公开数据库对它的描述

N-3,4-dimethylisoxazol-5-yl-N-sulfanilylacetamide · CAS 80-74-0 · C13H15N3O4S. UNII WBT5QH3KED. Melting Point: 192.

物理形态与操作说明

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。